Occult triple negative male breast cancer. The usefulness of molecular platforms. A case report

We report a case of a 68-year-old man who developed an advanced Triple-Negative Breast Cancer (TNBC) presented as a Carcinoma of Unknown Primary (CUP) at diagnoses. After progressing to first line therapy, the molecular platform EPICUP® was performed and the results suggested breast cancer as origin...

Full description

Bibliographic Details
Main Authors: Angelats L, Estival A, Martinez-Cardús A, Musulen E, Margelí M
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666621921000466